This is just depressing. I don't even know if my insurance will be able to cover this drug. Check out this paragraph from an article I just read at <a target=_blank class=ftalternatingbarlinklarge href="http://blogs.forbes.com/sciencebiz/2010/02/hope-for-muscular-dystrophy-patients/?boxes=financechannelforbes
">http://blogs.forbes.com/scienc...=financechannelforbes
</a>
"Schoenebaum says that the results could be good news for PTC's partner, Genzyme, which plans to sell ataluren outside the U.S.. He estimates that there are 1,200 patients that could receive the drug. Assuming that half of them wind up taking it and that it costs $150,000 annually</b>, this would mean $100 million in total sales. That would increase Genzyme's 2014 earnings per share by 4%, Schoenebaum writes. If ataluren works in cystic fibrosis, where it is also being tested, that could mean another $400 million in sales for Genzyme, boosting earnings per share by 20%. CF results for the drug aren't expect until next year.".
$150, 000 Anually. What you guys think about this?
">http://blogs.forbes.com/scienc...=financechannelforbes
</a>
"Schoenebaum says that the results could be good news for PTC's partner, Genzyme, which plans to sell ataluren outside the U.S.. He estimates that there are 1,200 patients that could receive the drug. Assuming that half of them wind up taking it and that it costs $150,000 annually</b>, this would mean $100 million in total sales. That would increase Genzyme's 2014 earnings per share by 4%, Schoenebaum writes. If ataluren works in cystic fibrosis, where it is also being tested, that could mean another $400 million in sales for Genzyme, boosting earnings per share by 20%. CF results for the drug aren't expect until next year.".
$150, 000 Anually. What you guys think about this?